healthcare antitrust
Pfizer Completes $5.4 Billion Acquisition of Sickle Cell Disease Drug Innovator
Pfizer Inc. has acquired Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company whose leading product inhibits harmful medical conditions that lead to the relatively…
Courts Reject Two DOJ Merger Challenges as Another is On Trial
A brief setback for Biden’s war on anticompetitive deals? The number of mergers globally in 2021, according to PwC, was the biggest on record with…
FTC Sues to Block Illumina/Grail Deal
The Federal Trade Commission has filed an administrative complaint and authorized a federal court lawsuit to block Illumina’s $7.1 billion proposed acquisition of Grail —…
Hospital Merger Activity and Challenges: Two Conclude, One Merger Abandoned
Deal activity in the trillion-dollar U.S. patient-care industry has been hardy, despite projections that the pandemic might have slowed things down. That means the federal…